Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Year range
1.
Niger. j. surg. sci ; 20(2): 55-60, 2010.
Article in English | AIM | ID: biblio-1267557

ABSTRACT

The aim is to ascertain the pattern and frequency of vulval tumours as seen at the University of Port Harcourt Teaching Hospital. Forty (40) vulval tumours were used for the study. Twenty nine (72.5) were benign and eleven (27.5) were malignant. Patients of age 50 years and above were most affected 24(60). The most common clinical presentation was elevated and ulcerated plaques9 (22.5). Condyloma accummatum was the most common benign tumour while squamous cell carcinoma was the most common malignant tumour. It is concluded that vulval tumours are rare in this environment and that the malignant variants present at advanced stage of the disease in later ages. They constitute a remarkable morbidity and mortality especially in the obese and chronically ill menopausal women


Subject(s)
Signs and Symptoms , Vulvar Neoplasms/classification , Vulvar Neoplasms/etiology
2.
Dermatol. argent ; 15(5): 344-349, 2009. ilus, graf
Article in Spanish | LILACS | ID: lil-719837

ABSTRACT

Introducción. El carcinoma de células escamosas de la vulva constituye el 1 al 4 % de los tumores en la mujer, y ocupa el cuarto lugar de las neoplasias del tracto genital femenino. Objetivos. Determinar la incidencia de carcinoma epidermoide de vulva, e identificar el grado de invasión. Material y métodos. Se realizó un estudio retrospectivo, observacional de las pacientes atendidas en el consultorio de patología vulvar durante 4 años y 8 meses. Se estudiaron 28 mujeres con diagnóstico clínico e histopatológico de carcinoma de células escamosas. Resultados. Del total de pacientes evaluadas en el consultorio, 6,17% (28) presentó carcinoma de células escamosas. La edad promedio fue de 62,5 años. De las 28 pacientes, el 64,28% (18) presentó carcinoma de células escamosas invasor y el 35,7% (10) VIN, cuatro desarrollados a partir de liquen escleroso, tres con displasia epitelial (VIN diferenciado) y tres con diagnóstico de papulosis bowenoide (VIN usual). Todas las pacientes refirieron como signo predominante prurito y el tabaquismo se detectó en el 60% de los casos. Conclusiones. Se presentan 28 casos de carcinoma epidermoide vulvar: el 64,2 % fue invasor y el 35,7% neoplasia intraepitelial (VIN). De ésta el 70% correspondió a VIN diferenciado y el 30% restante a VIN usual. Esta casuística nos ha permitido conocer la incidencia de neoplasia epitelial vulvar en nuestro medio además de poder diferenciar los grados de invasión y factores patogénicos.


Introduction. The squamous cell carcinoma of the vulva constitutesbetween 1 and 4% of cancers affecting women, occupying fourthplace among neoplasias of the female genital tract.Objetives. To determine the incidence of squamous cell carcinomaof the vulva and identify grade of invasion.Material and methods. An observational retrospective study wasconducted, in which 28 patients were studied with clinical and pathologicaldiagnosis of squamous cell carcinoma of the vulva.Results. Of the total genital carcinomas in our hospital, the vulvarcarcinomas accounted for 6.17% of the genital tract tumours. Of the28 patients included in the study, 18 invasive carcinomas (64.28%)were detected and 10 vulvar intraepidermal neoplasia (VIN 35.7%).The average age of incidence was 62.5 years. The predominantsymptom was pruritus, and the most significant signs were tumour.In the 10 patients that were diagnosed with VIN, 4 developed froma lichen sclerosus, 3 from epithelial dysplasia and 3 with papulosisbowenoide. 60% of patients were smokers.Conclusions. 28 cases of epidermoide carcinoma of the vulva werestudied resulting in 64.2% invasive and 35.7% VIN. Of the latter, 70%corresponded to differentiated VIN and 30% usual VIN. This casuistryhas permitted us to observe the incidence of squamous cell carcinomain our region, and allowed us to differentiate the grades of invasionand pathogenic factors (Dermatol Argent 2009;15(5):344-349).


Subject(s)
Female , Carcinoma, Squamous Cell/pathology , Vulvar Neoplasms/classification , Vulvar Neoplasms/pathology , Carcinoma in Situ/pathology , Vulva/pathology
SELECTION OF CITATIONS
SEARCH DETAIL